Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: reply
Keiji Nogami
Department of Pediatrics, Nara Medical University, Kashihara, Japan
Correspondence: Keiji Nogami, Department of Pediatrics, Nara Medical University, 840 Shijo‐cho, Kashihara, Nara 634‐8522, Japan|Tel.: +81 744 29 8881|E‐mail:
ISTH Academy. Nogamimi K. Mar 1, 2019; 273406
Keiji Nogamimi
Keiji Nogamimi
Login now to access Regular content available to all registered users.

Access to Premium content is currently a membership benefit.

Click here to join ISTH or renew your membership.

You may also access ISTH content "anytime, anywhere" with the FREE ISTH Academy App for iOS and Android.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies